A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date10/18/19 → …